natgillin/translations-raw huggingface dataset:
The requirement for ex-ante approval by the Commission of managing, paying and implementing functions for measure 101 ‘Investments in agriculture holdings to restructure and to upgrade to community standards’ and measure 103 ‘Investments in the processing and marketing of agricultural and fishery products to restructure these activities and to upgrade them to Community standards’ by the Republic of Croatia for in Article 18 of Regulation (EC) No 718/2007, is hereby waived.
V skladu s členom 18 Uredbe (ES) št. 718/2007 se odstopa od zahteve po predhodni kontroli s strani Komisije glede funkcij upravljanja, plačevanja in izvajanja, ki se prenašajo na Hrvaško, za ukrep št. 101 „naložbe v kmetijska gospodarstva, da se prestrukturirajo in nadgradijo na standarde Skupnosti“, in ukrep št. 103 „naložbe v predelavo in trženje kmetijskih in ribiških proizvodov, da se te dejavnosti prestrukturirajo in nadgradijo na standarde Skupnosti“.
This Decision shall apply on the basis of the following structures, bodies and authorities designated by the Republic of Croatia for the management of measures 101 and 103 of the Programme provided for under IPA — Component V:
Ta sklep se uporablja na podlagi naslednjih struktur, teles in organov, ki jih je Republika Hrvaška imenovala za upravljanje ukrepov 101 in 103 programa, predvidenega v okviru komponente V iz IPA:
the National Authorising Officer;
nacionalni odredbodajalec;
the National Fund;
nacionalni sklad;
the Operating Structure for IPA — Component V:
operativna struktura za IPA – komponenta V:
the Managing Authority,
organ upravljanja,
the IPARD Agency.
agencija IPARD.
The management powers are conferred on the structures, bodies and authorities as specified in Article 2 of this Decision.
Upravljavska pooblastila se prenašajo na strukture, telesa in organe, kot so opredeljeni v členu 2 tega sklepa.
The national authorities shall carry out further verifications with regard to the structures, bodies and authorities set out in Article 2 of this Decision, in order to ensure that the management and control system operates satisfactorily.
Nacionalni organi opravijo nadaljnja preverjanja glede struktur, teles in organov iz člena 2 tega sklepa, da bi zagotovili zadovoljivo delovanje sistema.
Verifications shall be carried out before the submission of the first Declaration of Expenditure requesting the reimbursement related to measures stated in Article 1(2) above.
Preverjanja se opravijo pred predložitvijo prve izjave o izdatkih z zahtevo po povračilu za ukrepe, navedene v členu 1(2).
Expenditure paid earlier than the date of this Decision shall in no case be eligible with the exception of general costs referred to in Article 172(3c) of Regulation (EC) No 718/2007.
Izdatki, izplačani pred datumom tega sklepa o prenosu, niso upravičeni do sofinanciranja, razen splošnih stroškov iz člena 172(3c) Uredbe (ES) št. 718/2007.
Without prejudice to any decisions granting aid under the IPARD Programme to individual beneficiaries, the rules for eligibility of expenditure proposed by Croatia by letter No ‘Class: NP 018-04/09-01/106, Ref. number: 525-12-3-0472/09-2’ of 16 March 2009 and registered in the Commission on 26 March 2009 under No 8151 shall apply.
Brez poseganja v morebitne sklepe, s katerimi je bila posameznim upravičencem dodeljena pomoč v okviru programa IPARD, veljajo pravila za upravičenost izdatkov, ki jih je predlagala Hrvaška v dopisu št. „Class: NP 018-04/09-01/106, sklicna številka: 525-12-3-0472/09-2“ z dne 16. marca 2009, registriranem pri Komisiji 26. marca 2009 pod št. 8151.
The Commission shall monitor compliance with the requirements for the conferral of management powers as laid down in Article 17 of Regulation (EC) No 718/2007.
Komisija spremlja izpolnjevanje zahtev za prenos upravljavskih pooblastil v skladu s členom 17 Uredbe (ES) št. 718/2007.
At any time during the implementation of this Decision, should the Commission consider that the obligations of the Republic of Croatia under this Decision are no longer met, the Commission may decide to withdraw or suspend the conferral of management powers.
Če Komisija kadar koli med izvajanjem tega sklepa meni, da Republika Hrvaška ne izpolnjuje več obveznosti iz tega sklepa, lahko Komisija odloči, da prekliče ali prekine prenos upravljavskih pooblastil.
establishing a European Union Committee of Experts on Rare Diseases
o ustanovitvi Odbora strokovnjakov Evropske unije za redke bolezni
The Commission White Paper ‘Together for health: a strategic approach for the EU 2008-2013’ [1] adopted by the Commission on 23 October 2007, developing the EU health strategy, identified rare diseases as a priority for action.
Bela knjiga Komisije „Skupaj za zdravje: strateški pristop EU za obdobje 2008–2013“ [1], ki jo je Komisija sprejela 23. oktobra 2007 in ki vsebuje zdravstveno strategijo EU, je določila redke bolezni za prednostno področje ukrepanja.
In parallel, the European Parliament and the Council adopted Decision No 1350/2007/EC of 23 October 2007 establishing a second programme of Community action in the field of health (2008 to 2013) [2].
Hkrati sta Evropski parlament in Svet sprejela Sklep št. 1350/2007/ES z dne 23. oktobra 2007 o uvedbi drugega programa ukrepov Skupnosti na področju zdravja (2008–2013) [2].
According to Article 7(2) as well as to the Annex to that Decision, the actions in the field of generation and dissemination of health information and knowledge shall be implemented in close cooperation with Member States developing consultation mechanisms and participatory processes.
V skladu s členom 7.2 in Prilogo k navedenemu sklepu se dejavnosti glede zbiranja in širjenja zdravstvenih informacij in znanja izvajajo v tesnem sodelovanju z državami članicami z oblikovanjem mehanizmov posvetovanja in postopkov sodelovanja.
The European Commission adopted on 11 November 2008 the ‘Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on rare diseases: Europe's challenges’ [3] (hereafter referred to as the Commission Communication) and the Council on 8 June 2009 a Council Recommendation on an action in the field of rare diseases [4] (hereafter referred to as the Council Recommendation).
(3) Evropska komisija je 11. novembra 2008 sprejela „Sporočilo Komisije Evropskemu parlamentu, Svetu, Evropskemu ekonomsko-socialnemu odboru in Odboru regij – Redke bolezni: izzivi za Evropo“ [3] (v nadaljnjem besedilu: Sporočilo Komisije), Svet pa je 8. junija 2009 sprejel Priporočilo o ukrepanju na področju redkih bolezni [4] (v nadaljnjem besedilu: Priporočilo Sveta).
The preparation and implementation of Community activities in the field of rare diseases require close cooperation with the specialised bodies in Member States and with the interested parties.
Priprava in izvajanje dejavnosti Skupnosti na področju redkih bolezni zahteva tesno sodelovanje s specializiranimi organi v državah članicah in zainteresiranimi stranmi.
Therefore, a framework is required for the purpose of regular consultations with those bodies, with the managers of projects supported by the European Commission in the fields of research and public health action and with other relevant stakeholders acting in the field.
Zato je potreben okvir za namen rednega posvetovanja z navedenimi organi, vodji projektov raziskovanja in dejavnosti na področju javnega zdravja, ki jih podpira Evropska komisija, in z drugimi ustreznimi zainteresiranimi stranmi, ki delujejo na tem področju.
This need for a framework was reflected in the Communication COM(2008) 679 final on rare diseases.
Potreba po okviru je izražena v Sporočilu COM(2008) 679 konč. o redkih boleznih.
Point 7 of the Communication recommended that the Commission be assisted by a European Union Advisory Committee on Rare Diseases.
V točki 7 Sporočila je priporočeno, da Komisiji pomaga Svetovalni odbor EU za redke bolezni.
The Committee shall not act as a Committee within the meaning of Council Decision 1999/468/EC of 28 June 1999 laying down the procedures for the exercise of implementing powers conferred on the Commission [5],
Odbor ne deluje kot odbor v smislu Sklepa Sveta 1999/468/ES z dne 28. junija 1999 o določitvi postopkov za uresničevanje Komisiji podeljenih izvedbenih pooblastil [5] –
The Commission hereby establishes a Committee of Experts on Rare Diseases, hereinafter referred to as ‘the Committee’.
Komisija ustanavlja Odbor strokovnjakov za redke bolezni (v nadaljnjem besedilu: odbor).
The Committee acting in the public interest shall assist the Commission in formulating and implementing the Community's activities in the field of rare diseases, and shall foster exchanges of relevant experience, policies and practices between the Member States and the various parties involved.
Odbor, ki deluje v javnem interesu, pomaga Komisiji pri oblikovanju in izvajanju dejavnosti Skupnosti na področju redkih bolezni ter spodbuja izmenjavo ustreznih izkušenj, politik in praks med državami članicami in različnimi vključenimi stranmi.
The tasks of the Committee shall not comprise issues covered by Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products [6] and issues that fall under the tasks of the Committee of Orphan Medicinal Products (COMP), set up by Article 4 of that Regulation, nor issues that fall under the tasks of the Pharmaceutical Committee, set up by Council Decision 75/320/EEC [7].
Naloge odbora ne vključujejo področij, zajetih z Uredbo (ES) št. 141/2000 Evropskega parlamenta in Sveta z dne 16. decembra 1999 o zdravilih sirotah [6], področij, ki sodijo med naloge Odbora za zdravila sirote, ustanovljenega s členom 4 navedene uredbe, in področij, ki sodijo med naloge Odbora za farmacijo, ustanovljenega s Sklepom Sveta 75/320/EGS [7].
assist the Commission in the monitoring, evaluating and disseminating the results of measures taken at Community and national level in the field of rare diseases;
pomaga Komisiji pri spremljanju, ocenjevanju in širjenju rezultatov ukrepov, sprejetih na ravni Skupnosti in nacionalni ravni na področju redkih bolezni;
contribute to the implementation of Community actions in the field, in particular by analysing the results and suggesting improvements to the measures taken;
prispeva k izvajanju dejavnosti Skupnosti na tem področju, zlasti z analizo rezultatov in predlogi za izboljšave sprejetih ukrepov;
contribute to the preparation of Commission reports on the implementation of the Commission Communication and the Council Recommendation;
prispeva k pripravi poročil Komisije o izvajanju Sporočila Komisije in Priporočila Sveta o ukrepanju na področju redkih bolezni;
deliver opinions, recommendations or submit reports to the Commission either at the latter's request or on its own initiative;
pripravlja mnenja in priporočila ali predloži poročila Komisiji na njeno ali lastno pobudo;
assist the Commission in international cooperation on matters relating to rare diseases;
pomaga Komisiji pri mednarodnem sodelovanju glede vprašanj v zvezi z redkimi boleznimi;
assist the Commission in drawing up guidelines, recommendations and any other action defined in the Commission Communication and in the Council Recommendation;
pomaga Komisiji pri oblikovanju smernic, priporočil in kakršnih koli drugih dejavnosti, opredeljenih v Sporočilu Komisije in Priporočilu Sveta;
provide an annual report of its activities to the Commission.
predloži Komisiji letno poročilo o svojih dejavnostih.
The Committee shall adopt its rules of procedure in agreement with the Commission.
Odbor sprejme pravilnik v soglasju s Komisijo.
The Committee shall comprise 51 members and the corresponding alternates, namely:
Odbor sestavlja 51 članov in njihovih namestnikov, in sicer:
one representative per Member State from ministries or government agencies responsible for rare diseases; the representative shall be designated by the government of each Member State;
en predstavnik na državo članico iz ministrstev ali vladnih služb, pristojnih za redke bolezni; predstavnika imenuje vlada vsake države članice;
four representatives from patients' organisations;
štirje predstavniki združenj bolnikov;
four representatives of the pharmaceutical industry;
štirje predstavniki farmacevtske industrije;
nine representatives of ongoing and/or past Community projects in the field of rare diseases financed by the programmes of Community action in the field of health [8] including three members of the pilot European Reference Networks on rare diseases;
devet predstavnikov tekočih in/ali nekdanjih projektov Skupnosti na področju redkih bolezni, ki se financirajo iz programov ukrepov Skupnosti na področju zdravja [8], vključno s tremi predstavniki pilotne evropske referenčne mreže za redke bolezni;
six representatives of the ongoing and/or past rare diseases projects financed by the Community Framework Programmes for Research and Technological Development [9];
šest predstavnikov tekočih in/ali nekdanjih projektov o redkih boleznih, ki se financirajo iz okvirnih programov Skupnosti za raziskave in tehnološki razvoj [9];
one representative of the European Centre for Disease Prevention and Control (ECDC), whose mandate, established in accordance with Regulation (EC) No 851/2004 of the European Parliament and of the Council of 21 April 2004 establishing a European Centre for disease prevention and control [10] includes activities on rare emerging infectious diseases.
en predstavnik Evropskega centra za preprečevanje in obvladovanje bolezni, ustanovljenega z Uredbo (ES) št. 851/2004 Evropskega parlamenta in Sveta z dne 21. aprila 2004 o ustanovitvi Evropskega centra za preprečevanje in obvladovanje bolezni [10], čigar pooblastila vključujejo dejavnosti v zvezi z redkimi novimi nalezljivimi boleznimi.
On request of the governments of the States concerned, the Commission can decide to extend the composition of the Committee with a representative of each of the EFTA States which are party to the Agreement on the European Economic Area, from the ministry or government agency responsible for rare diseases and designated by the government of the State concerned.
Komisija lahko na zahtevo vlad zadevnih držav razširi sestavo odbora s po enim predstavnikom vsake države Efte, ki je podpisnica Sporazuma o Evropskem gospodarskem prostoru, iz ministrstev ali vladnih služb, pristojnih za redke bolezni, imenuje pa ga vlada zadevne države.
Representatives of the Commission, of the European Medicines Agency (EMEA) as well as the Chair or Vice-Chair of the Committee for Orphan Medicinal Products (COMP) may attend the meetings of the Committee.
Predstavniki Komisije, Evropske agencije za zdravila (EMEA) ter predsednik ali podpredsednik Odbora za zdravila sirote se lahko udeležijo sej odbora.
Representatives of international and professional organisations and other associations acting in the field of rare diseases making duly substantiated requests to the Commission may be given observer status.
Status opazovalca lahko dobijo predstavniki mednarodnih in strokovnih organizacij ter drugih združenj, delujočih na področju redkih bolezni, ki predložijo utemeljeno zahtevo Komisiji.
The Commission shall appoint the members of the Committee corresponding to groups (b) to (e) of paragraph 1 from a list of suitable candidates established following publication of a call for expressions of interest in the Official Journal of the European Union and on the Commission website.
Komisija imenuje člane odbora iz skupin b) do e) odstavka 1 s seznama ustreznih kandidatov, ki se pripravi po objavi razpisa za prijavo interesa v Uradnem listu Evropske unije in na spletišču Komisije.
The call for expressions of interests shall specify the required qualifications and conditions to become member of the Committee.
V razpisu za prijavo interesa se opredelijo kvalifikacije in pogoji za pridobitev statusa člana odbora.
All members of the Committee shall undertake to act in the public interest.
Vsi člani odbora se obvežejo, da bodo delovali v javnem interesu.
Members of the Committee corresponding to groups (b) to (e) shall undertake to act in an independent manner.
Člani odbora iz skupin b) do e) se obvežejo, da bodo delovali neodvisno.
They are under no power of direction from their body of origin when carrying out their tasks as Committee member.
Pri izvajanju svojih nalog člani odbora ne sprejemajo nobenih navodil matičnega organa.
The term of office of members of the Committee shall be three years and shall be renewable.
Mandat članov odbora je tri leta in je obnovljiv.
They shall remain in office until such time as they are replaced.
Člani odbora ostanejo na svojih položajih do zamenjave.
A member's term of office shall come to an end before the expiry of the three-year period in the event of her/his resignation, the termination of her/his membership of the organisation which she/he represents, permanent incapacity to attend the meetings, incapacity to contribute effectively to the committee's deliberations, non-respect of the conditions set in Article 287 of the Treaty establishing the European Community, or in case of subsequent non-compliance with the qualifications and conditions specified in the call for expression of interests.
Mandat člana se prekine pred iztekom triletnega obdobja v primeru odpovedi, prekinitve članstva v organizaciji, ki jo predstavlja, trajne nezmožnosti udeležbe na sejah, nezmožnosti učinkovitega prispevanja k doseganju ciljev odbora, neupoštevanja pogojev iz člena 287 Pogodbe o ustanovitvi Evropske skupnosti ali v primeru naknadnega neizpolnjevanja kvalifikacij in pogojev iz razpisa za prijavo interesa.
A member's terms of office may also be terminated if the organisation which nominated her/him requests her/his replacement.
Njegov mandat se lahko tudi prekine, če organizacija, ki ga je imenovala, zahteva njegovo zamenjavo.
Members whose term of office comes to an end before the expiry of the three-year period may be replaced for the remaining period of their mandate.
Člane, katerih mandat se prekine pred iztekom triletnega obdobja, je mogoče zamenjati za preostalo obdobje njihovega mandata.
The Committee shall elect a chairperson and three vice-chairpersons, with a one-year term of office, from different categories of members of the Committee, in accordance with the procedure laid down in Article 10.
Odbor izvoli predsednika in tri podpredsednike iz različnih skupin članov odbora z enoletnim mandatom v skladu s postopkom iz člena 10.
The vice-chairpersons shall stand in for the chairperson in the absence of the chairperson.
Podpredsedniki nadomeščajo predsednika, kadar je ta odsoten.
The chairperson and vice-chairpersons together with a representative of the Commission shall constitute the Bureau of the Committee, which shall prepare the work of the Committee.
Predsednik, podpredsedniki in predstavnik Komisije sestavljajo predsedstvo odbora, ki pripravlja delo odbora.
The Secretariat of the Committee shall be provided by the Commission.
Sekretariat odbora zagotovi Komisija.
The minutes of the Committee's meetings shall be drawn up by the Commission.
Komisija pripravlja zapisnike sej odbora.
The Bureau of the Committee may invite any person who is specially qualified in a particular subject on the agenda to take part in the work of the Committee as an external expert.
Predsedstvo odbora lahko povabi katero koli osebo, ki je posebej usposobljena za določeno temo dnevnega reda, da sodeluje kot zunanji strokovnjak pri delu odbora.
External experts shall only take part in the work on the particular subject for which their attendance is requested.
Zunanji strokovnjaki sodelujejo samo pri delu v zvezi s posamezno temo, za katero se zaprosi njihova navzočnost.
The Committee may set up temporary working groups.
Odbor lahko ustanovi začasne delovne skupine.
These groups may notably be established when work of a temporary or ad-hoc nature is required such as preparation of proposals on a specific scientific topic, or preparation of responses to specific questions raised by the Committee in relation to specific scientific fields.
Te skupine se lahko ustanovijo začasno ali priložnostno, na primer zaradi priprave predlogov za posebno znanstveno temo ali priprave odgovorov na posebna vprašanja, ki jih postavi Komisija v zvezi s posebnimi znanstvenimi temami.
Working groups consist of external experts selected according to their specific expertise.
Delovne skupine sestavljajo zunanji strokovnjaki, ki so izbrani glede na posebno strokovno znanje.
The Committee shall adopt a mandate for each working group, indicating its objectives, composition, meeting frequency and the duration of its activity.
Odbor sprejme mandat za vsako delovno skupino, v katerem opredeli cilje, sestavo, pogostost sej in obdobje delovanja delovne skupine.
For the preparation of its opinions, the Committee may entrust a rapporteur, who can be one of its members or an external expert, with the task of drawing up reports in accordance with its rules of procedure.
Odbor lahko za pripravo svojih mnenj poročevalcu, ki je lahko član ali zunanji strokovnjak, da nalogo, da pripravi poročila v skladu s pravilnikom.
One or more members of the Committee may be nominated by the Committee to participate as observers in the activities of other expert groups of the Commission.
Odbor lahko enega ali več članov odbora imenuje, da sodelujejo kot opazovalci v dejavnostih drugih strokovnih skupin Komisije.
No remuneration shall be attached to a member's duties; travelling and subsistence expenses for meetings of the Committee and of the working groups set up under Article 7 shall be met by the Commission in accordance with the administrative rules in force.
Delo članov v odboru ni plačano; potne stroške in dnevnice za seje odbora in delovnih skupin, ustanovljenih po členu 7, krije Komisija v skladu z veljavnimi upravnimi predpisi.
Measures adopted under Articles 6 and 7 having financial implications for the budget of the European Communities shall be submitted for the prior agreement of the Commission and shall be implemented in accordance with the Financial Regulation applicable to the general budget of the European Communities.
Ukrepi, sprejeti v skladu s členoma 6 in 7, ki imajo finančne posledice za proračun Evropskih skupnosti, se predložijo Komisiji v predhodno odobritev in izvajajo v skladu z veljavno finančno uredbo, ki se uporablja za splošni proračun Evropskih skupnosti.
The Committee shall be convened by the Commission and shall meet on its premises.
Odbor se sestane v prostorih Komisije na njeno povabilo.
It shall meet at least three times per year.
Sestane se najmanj trikrat na leto.
The quorum required for the adoption of opinions, reports or recommendations by the Committee shall be reached when two thirds of the total members of the Committee are present.
Sklepčnost, ki je potrebna za sprejetje mnenj, poročil ali priporočil odbora, je dosežena, ko sta navzoči dve tretjini vseh članov odbora.
Whenever possible, scientific opinions, reports or recommendations of the Committee shall be taken by consensus.
Znanstvena mnenja, poročila ali priporočila odbora se vedno, ko je mogoče, sprejmejo s soglasjem.
If such a consensus cannot be reached, the opinion shall be adopted by a majority of the Committee members who are present.
Če ga ni mogoče doseči, se mnenje sprejme z večino navzočih članov odbora.
The Commission, when requesting the Committee's opinion or a recommendation, may set a deadline within which the opinion should be delivered.
Kadar Komisija zahteva mnenje ali priporočilo odbora, lahko določi rok, v katerem mora biti mnenje dano.
Draft opinions and recommendations can, after approval of the Chairperson, be submitted by the Secretariat to the Committee for adoption by a written procedure to be laid down in the rules of procedure of the Committee.
Osnutki mnenj in priporočil se lahko po odobritvi predsednika predložijo sekretariatu odbora v sprejetje po pisnem postopku, ki se določi v poslovniku odbora.
However, such written procedures should be, as much as possible, restricted to urgent measures required to be taken between scheduled meetings.
Vendar morajo biti takšni pisni postopki čim bolj omejeni na nujne ukrepe, ki jih je treba sprejeti med rednimi sejami.